David Carney

David Carney

Directeur/Bestuurslid bij
Checkin Innovative Care Technologies, Inc.
Technology Services
Distribution Services
Finance

Profiel

Mr. Carney is an experienced health care executive having held a variety of leadership roles at both late stage companies.
He is an experienced investor in seed stage companies and a serial healthcare entrepreneur who has founded or managed multiple early-stage companies including MegaSource (acquired by Cerner), CareInsite (merged with Healtheon), Sun Clinical Data Institute (internal start-up for Eclipsys) and Correlagen (acquired by LabCorp).
Since the Correlagen acquisition, David has become active in three seed stage investment groups located in Massachusetts, North Carolina and California; and is chair or co-chair of the screening committee for two of these groups.
These investor groups enable access to seed stage companies across the U.S.
David is an active board member of several early stage health care companies.
David holds a mechanical engineering and MBA degrees from the University of Michigan

Actieve functies van David Carney

BedrijvenFunctieBegin
Directeur/Bestuurslid -
Directeur/Bestuurslid 29-09-2021

Eerdere bekende functies van David Carney

BedrijvenFunctieEinde
Corporate Officer/Principal 01-01-2010
Corporate Officer/Principal 01-01-2005
CERNER CORPORATION Corporate Officer/Principal 01-01-1995
Private Equity Investor -
MCKESSON CORPORATION Corporate Officer/Principal -
Ervaring van David Carney in detail bekijken

Opleiding van David Carney

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

21

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Technology Services

Distribution Services

Technology Services

Technology Services

Technology Services

Technology Services

Finance

Consumer Services

Commercial Services

Technology Services

Technology Services

  1. Beurs
  2. Insiders
  3. David Carney
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU